Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Navigating “the big holiday spend” this tax-loss season

Tax-loss season is on the minds of many investors right now. It is the time of year when some traders feel compelled to dump their losers – and lock-in losses. It has been a hot topic on the...
Jonathon Brown | December 8, 2022 |

Help 9 cent GEN.T save lives with cancer screening

Friday, March 4, 2016 | www.tickertrax.com | Help 9 Cent GEN.T Save Lives with Cancer Screening By Danny Deadlock, TickerTrax Note : I have been working on this report all day (s...
Danny Deadlock | March 4, 2016 |

Topline Results from Lipid-Lowering Trial 'Just What the Doctor Ordered'

The study data and their implications are provided in a BTIG report. In an Aug. 29 research note, BTIG analyst Thomas Shrader reported that just released topline data are "as hoped" from Esperion Therapeutics Inc.'s (ESPR:NASDAQ) Phase 2 trial of bempedoic acid-ezet...
Streetwise Reports | September 5, 2019 |

Kosmos Energy (NYSE: KOS): Invest in African oil

I’m one of those “dividend guys.” I believe dividend stocks should be the foundation of everyone’s portfolio. The reasons are simple: They’re constantly churning along, throwing off income and are ty...
Matthew Carr | October 28, 2012 |

Tax Loss Season: What Does the Broken Clock Setup Look Like?

Back in October 2018, Goldcorp was trading at its lowest level in 16 years. This was before Goldcorp merged with Newmont, one of the world’s largest and oldest gold producers. Goldcorp wasn’t alone. Shares of ...
Marin Katusa | December 6, 2019 |

Tax loss selling…is it a good time for investors?

Every year on Black Friday, shoppers anticipate great deals and are lined out the door to get a discount on a TV or on a much needed appliance. Buyers will go to many lengths, including camping outside the store to be the first in or even trampling on other shoppers to get t...
Dr. Kal Kotecha | December 11, 2019 |

Disruptive. Transformative. Empowering. Integrated Digital Care for the Future.

CareSpan Health Inc. ( TSX-V.CSPN , Forum ) is a disruptive, transformative, and empowering company providing a digital healthcare platform that integrates digital care tools, capabilities, and data in one place. The company's proprietary "Clinic-in-the Cloud" is a c...
Dave Jackson | January 24, 2022 |

The Debt Time Bomb: Amend, Extend and Pretend

“Hey Marin, we don’t invest in gold companies for yield. We invest in gold stocks as a hedge to the overall markets. And for leverage on the price of gold.” What a bunch of nonsense . Have you ever heard the phrase, “What a gold...
Marin Katusa | April 29, 2019 |

Gold, Silver, Miners Teater On The Brink Of A Breakout

This week has been a wild and emotional one and it’s just started! With Monday’s big pop in the stock indexes, the big rally was based on vaccine news and bullish comments from the fed, convincing most traders and investors to be overly...
Chris Vermeulen | May 20, 2020 |

A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.

When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...
Dave Jackson | January 31, 2022 |
1 2 3 4 5 6 7 8 9 10 ...